AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer

Summary

The purpose of this study is to find out what effects, administering infusions of AUY922 with hormonal therapy (letrozole) and oral targeted drug (lapatinib) will have on the patients with advanced breast cancer known as ER+ HER2 +.

Timeline

Start

2011-07

Primary completion

2012-08

Completion

2012-08

Drugs

Indications